Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

about

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

Item

http://www.wikidata.org/entity/Q47626278

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@en

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@nl

type

Item

label

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@en

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@nl

prefLabel

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@en

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@nl

P1476

Synthesis and Immunological Ev ...... ning a Long MUC1 Glycopeptide.

@en

P2093

Anju Sirohiwal

http://www.w3.org/2001/XMLSchema#string

Cathy S Madsen

http://www.w3.org/2001/XMLSchema#string

Chantelle J Capicciotti

http://www.w3.org/2001/XMLSchema#string

Nitin T Supekar

http://www.w3.org/2001/XMLSchema#string

Peter A Cohen

http://www.w3.org/2001/XMLSchema#string

Vani Lakshminarayanan

http://www.w3.org/2001/XMLSchema#string

P2860

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)

Synthetic self-adjuvanting glycopeptide cancer vaccines

Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono-, di-, tri-, and hexasaccharide glycodomains

Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis

Robust immune responses elicited by a fully synthetic three-component vaccine.

Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers

MUC1: a multifaceted oncoprotein with a key role in cancer progression.

Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist.

Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

P304

121-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CBIC.201700424

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Geert-Jan Boons

Margreet A Wolfert

Sandra J Gendler

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29120508

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

5975269

http://www.w3.org/2001/XMLSchema#string